CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal
h-var-3fbcfc0e6c
## Mechanistic Overview
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal starts from the claim that modulating CYP46A1 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal starts from the cl
Elo ratings (across arenas)
| Arena | Rating | RD | W-L-D | N |
|---|---|---|---|---|
| neurodegeneration | 1733 | ±67 | 28-26-0 | 54 |
| tournament:top50 | 1587 | ±254 | 2-0-0 | 2 |
Ancestry (oldest → this)
crossover · gen 1
parent: h-2600483e × h-61196ade
Descendants
(no variants yet)